Biorez has announced the election of Paul Hermes, Entrepreneur in Residence at Medtronic, to serve as an independent director on its board of directors.

Based in New Haven, Biorez is a privately held early-stage regenerative medicine company engaged in developing bioresorbable scaffold implants to reconstruct and regenerate functional tissue in vivo. Its lead product candidate is an off-the-shelf implant for ACL reconstruction that spares harvesting of patient donor-tissue, and provides a better alternative to cadaver-based allograft.